Articoli con mandati relativi all'accesso pubblico - Toni ChoueiriUlteriori informazioni
Non disponibili pubblicamente: 35
Controlla
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3 …
BI Rini, T Powles, MB Atkins, B Escudier, DF McDermott, C Suarez, ...
The Lancet 393 (10189), 2404-2415, 2019
Mandati: US National Institutes of Health
Controlla
Targeting the HIF2–VEGF axis in renal cell carcinoma
TK Choueiri, WG Kaelin Jr
Nature medicine 26 (10), 1519-1530, 2020
Mandati: Howard Hughes Medical Institute
Controlla
Beyond conventional immune-checkpoint inhibition—novel immunotherapies for renal cell carcinoma
DA Braun, Z Bakouny, L Hirsch, R Flippot, EM Van Allen, CJ Wu, ...
Nature reviews Clinical oncology 18 (4), 199-214, 2021
Mandati: US Department of Defense, US National Institutes of Health
Controlla
Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear‐cell renal cell carcinoma receiving vascular endothelial growth …
TK Choueiri, MM Regan, JE Rosenberg, WK Oh, J Clement, AM Amato, ...
BJU international 106 (6), 772-778, 2010
Mandati: US National Institutes of Health
Controlla
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups
BA Mahal, AA Aizer, DR Ziehr, AS Hyatt, JD Sammon, M Schmid, ...
Urology 84 (2), 386-392, 2014
Mandati: US National Institutes of Health
Controlla
Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer
MJ Krimphove, AP Cole, SA Fletcher, SS Harmouch, S Berg, SR Lipsitz, ...
Prostate cancer and prostatic diseases 22 (1), 125-136, 2019
Mandati: US Department of Defense
Controlla
Complications after metastasectomy for renal cell carcinoma—A population-based assessment
CP Meyer, M Sun, JA Karam, JJ Leow, G de Velasco, SK Pal, SL Chang, ...
European urology 72 (2), 171-174, 2017
Mandati: US National Institutes of Health
Controlla
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study
TK Choueiri, DF McDermott, J Merchan, TM Bauer, R Figlin, EI Heath, ...
The Lancet Oncology 24 (5), 553-562, 2023
Mandati: US National Institutes of Health
Controlla
Radiologic heterogeneity in responses to anti–PD-1/PD-L1 therapy in metastatic renal cell carcinoma
G de Velasco, KM Krajewski, L Albiges, MM Awad, J Bellmunt, FS Hodi, ...
Cancer Immunology Research 4 (1), 12-17, 2016
Mandati: US National Institutes of Health
Controlla
Comparative effectiveness of radical prostatectomy versus external beam radiation therapy plus brachytherapy in patients with high-risk localized prostate cancer
S Berg, AP Cole, MJ Krimphove, J Nabi, M Marchese, SR Lipsitz, ...
European Urology 75 (4), 552-555, 2019
Mandati: US Department of Defense, German Research Foundation
Controlla
ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma
P Khanna, HJ Soh, CH Chen, R Saxena, S Amin, M Naughton, PN Joslin, ...
Science translational medicine 13 (577), eabc0170, 2021
Mandati: US National Institutes of Health, Science Foundation Ireland
Controlla
Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials
P Ghatalia, Y Je, N El Mouallem, PL Nguyen, QD Trinh, G Sonpavde, ...
Critical Reviews in Oncology/Hematology 93 (3), 257-276, 2015
Mandati: US National Institutes of Health
Controlla
Quality of care in the treatment of localized intermediate and high risk prostate cancer at minority serving hospitals
MJ Krimphove, SA Fletcher, AP Cole, S Berg, M Sun, SR Lipsitz, ...
The Journal of urology 201 (4), 735-741, 2019
Mandati: US Department of Defense, German Research Foundation
Controlla
Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer
G Gandaglia, M Sun, JC Hu, G Novara, TK Choueiri, PL Nguyen, ...
European urology 66 (6), 1125-1132, 2014
Mandati: Fonds de recherche du Québec - Santé
Controlla
Morbidity and mortality of locally advanced prostate cancer: a population based analysis comparing radical prostatectomy versus external beam radiation
AS Feldman, CP Meyer, A Sanchez, A Krasnova, G Reznor, M Menon, ...
The Journal of Urology 198 (5), 1061-1068, 2017
Mandati: US Department of Defense
Controlla
Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010
AP Cole, D Dalela, J Hanske, SA Mullane, TK Choueiri, CP Meyer, ...
Urologic Oncology: Seminars and Original Investigations 33 (12), 504. e9-504 …, 2015
Mandati: US National Institutes of Health
Controlla
Neoadjuvant androgen deprivation therapy prior to radical prostatectomy: recent trends in utilization and association with postoperative surgical margin status
TR McClintock, N von Landenberg, AP Cole, SR Lipsitz, P Gild, M Sun, ...
Annals of surgical oncology 26, 297-305, 2019
Mandati: US Department of Defense
Controlla
Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality
YD Tseng, MH Chen, CJ Beard, NE Martin, PF Orio, M Loffredo, ...
The Journal of urology 187 (6), 2068-2073, 2012
Mandati: US National Institutes of Health
Controlla
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer
BA Mahal, DR Ziehr, AA Aizer, AS Hyatt, C Lago-Hernandez, TK Choueiri, ...
Journal of geriatric oncology 5 (4), 352-358, 2014
Mandati: US National Institutes of Health
Controlla
Obesity in relation to renal cell carcinoma incidence and survival in three prospective studies
RE Graff, KM Wilson, A Sanchez, SL Chang, DF McDermott, TK Choueiri, ...
European urology 82 (3), 247-251, 2022
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software